Lawyers USA has ceased publication. If you have purchased a research pass or still have additional time on your current Digital Subscription, you may access locked stories by logging in.
Justice Dept. joins Risperdal whistleblower suits
The U.S. Attorney's office in Boston announced that the Justice Department has filed a False Claims Act complaint against Johnson & Johnson and two subsidiaries for allegedly paying millions of dollars in kickbacks to nursing homes to prescribe its anti-psychotic drug Risperdal.